[1] 周玲, 朱梦蓉. 后零差率时代医院药学发展之刍议[J]. 中南药学, 2018, 16(4):563-566. doi:  10.7539/j.issn.1672-2981.2018.04.029
[2] 肖秘苏, 张剑萍, 郭澄, 等. 我院“六院药师”微信平台的初步建立与实践[J]. 中国药房, 2017, 28(7):998-1002. doi:  10.6039/j.issn.1001-0408.2017.07.38
[3] 翟文静, 熊大艳, 詹秦晋戈, 等. 基于互联网面向非住院患者的药学服务[J]. 宜春学院学报, 2016, 38(6):77-79, 82. doi:  10.3969/j.issn.1671-380X.2016.06.021
[4]

WAN L L, LU J, FU J L, et al. Acetylcholinesterase inhibitor donepezil effects on plasma β-hydroxybutyrate levels in the treatment of Alzheimer's disease[J]. Curr Alzheimer Res,2018,15(10):917-927. doi:  10.2174/1567205015666180601091818
[5]

LU J, FU J L, ZHONG Y, et al. Association between ABCA1 gene polymorphisms and the therapeutic response to donepezil therapy in Han Chinese patients with Alzheimer's disease[J]. Brain Res Bull,2018,140:1-4. doi:  10.1016/j.brainresbull.2018.03.014
[6]

LU J, FU J L, ZHONG Y, et al. The roles of apolipoprotein E3 and CYP2D6 (rs1065852) gene polymorphisms in the predictability of responses to individualized therapy with donepezil in Han Chinese patients with Alzheimer's disease[J]. Neurosci Lett,2016,614:43-48. doi:  10.1016/j.neulet.2015.12.062
[7]

LU J, WAN L L, ZHONG Y, et al. Stereoselective metabolism of donepezil and steady-state plasma concentrations of S-donepezil based on CYP2D6 polymorphisms in the therapeutic responses of Han Chinese patients with Alzheimer's disease[J]. J Pharmacol Sci,2015,129(3):188-195. doi:  10.1016/j.jphs.2015.10.010
[8] 上海市卫生计生委.加强用药安全!上海这77家医院今年全部开设药学门诊[N/OL]. [2018-08-06]. https://mp.weixin.qq.com/s/XX3gkTy1xxmgAFB8ulREBQ.
[9] 杨全军, 郭澄, 徐嵘, 等. 我院事前实时干预、事中互动审方和事后点评分析一体化用药决策系统的建设[J]. 中国药房, 2017, 28(35):5016-5019. doi:  10.6039/j.issn.1001-0408.2017.35.33
[10] 广东省药学会. 药学门诊试行标准[J]. 今日药学, 2018, 28(11):721-726.
[11] 范璟蓉, 李歆. 美国合作药物治疗管理及对我国的启示[J]. 中国新药杂志, 2011, 20(23):2381-2386.
[12] 喻鹏久, 谭涵梦, 刘亮辉, 等. 某院药师协议处方制度的构建与实践探索[J]. 今日药学, 2018, 28(11):749-751. doi:  10.12048/j.issn.1674-229X.2018.11.008